Journal
CURRENT OPINION IN NEUROBIOLOGY
Volume 61, Issue -, Pages 10-22Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.conb.2019.11.008
Keywords
-
Categories
Funding
- Hans & Ilse Breuer Foundation (Frankfurt am Main, Germany)
Ask authors/readers for more resources
Staging of neurodegenerative diseases is based chiefly on the topographical or anatomical extent of aggregated proteinaceous inclusions, and the density or severity of the lesions in a given region is usually assessed semiquantitatively. Associated phenomena, such as cell loss and synapse loss, are evaluated but not staged. This article reviews the development of neuropathological staging of the sporadic Alzheimer's and sporadic Parkinson's diseases. It considers challenges for staging systems, and it poses the question whether neuropathological staging as practiced up to now is still relevant.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available